G. Iaccarino

Tumor flare reactions and response to lenalidomide in patients with refractory classic Hodgkin lymphoma

F. Russo, S. Lastoria, F. Frigeri, 2009, American journal of hematology.

Elevation of clonal serum free light chains in patients with HIV‐negative primary effusion lymphoma (PEL) and PEL‐like lymphoma

A. De Chiara, F. Frigeri, R. Di Francia, 2009, British journal of haematology.

Abnormally Elevated Levels of Serum Free-Immunoglobulin Light Chains Are Frequently Found in Classic Hodgkin Lymphoma (cHL) and Predict Outcome of Patients with Early Stage Disease.

G. Castello, F. Russo, F. Frigeri, 2009 .

Childhood Therapy-Related Acute Myeloid Leukemia with t(16;21)(q24;q22)/RUNX1-CBFA2T3 After a Primitive Neuroectodermal Tumor of the Chest Wall.

E. Pota, Concetta Meo, A. Pinto, 2020, Clinical lymphoma, myeloma & leukemia.

Response and Toxicity to Cytarabine Therapy in Leukemia and Lymphoma: From Dose Puzzle to Pharmacogenomic Biomarkers

C. Cafiero, A. Re, A. Micera, 2021, Cancers.

Primary plasmacytoma of the breast.

L. Terracciano, A. De Chiara, S. Losito, 2001, Archives of pathology & laboratory medicine.

Pharmacological Profile and Pharmacogenomics of Anti-Cancer Drugs Used for Targeted Therapy.

M. Saggese, M. Berretta, F. Frigeri, 2017, Current cancer drug targets.

Three‐year results of MIM salvage treatment for refractory/relapsed intermediate grade NHL

S. Tafuto, G. Abate, G. Corazzelli, 1995, European journal of haematology.